Pain in Palliative Care: Tx Flashcards

1
Q

Management of Pain

A

 By the ladder
 By the mouth
 By the clock
 With breakthrough dosing
 Individualized for patient
 Address all aspects of suffering
 Monitor efficacy regularly
 Identify and treat underlying causes (if feasible)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Classification of Pain

A

 Using numerical
rating scale (1-10)
(from ESAS-r)
◦ Mild pain (1-3)
◦ Moderate pain (4-6)
◦ Severe pain: 7-10
 WHO analgesic ladder

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

WHO Ladder for Pain Control

A

Step 1
Mild Pain
Step 2
Moderate Pain
Step 3
Severe Pain

Non-opioids
Acetaminophen
NSAIDS
+/- Adjuvants

Weak opioids
Codeine
Tramadol
+/- Adjuvants

Strong opioids
Morphine
Hydromorphone

◦ Laxatives should be prescribed in most cases (opioids)
◦ Insufficient evidence to support/refute Step 2
opioids (eg. codeine) are superior to NSAIDS
◦ In rapidly progressing pain Step 2 may be omitted
 Use low doses of Step 3 analgesics (eg. morphine)
 Need to adjust dosing
◦ Geriatrics, and those with decreased cognitive or
organ function.
◦ Opioid tolerant or history of opioid misuse

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

 Oral route is preferred

A

◦ Easier to administer
◦ Cheaper
◦ No special techniques
required
◦ No specialized pharmacy
◦ No risk of infection
◦ Less painful
 May not be possible if:
◦ Malabsorption from gut
 Short gut, bowel obstruction
 Nausea/vomiting
◦ Patient delirious/unresponsive

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

By the clock

A

 Continuous pain
or pain which
occurs
frequently,
requires around
the clock
analgesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Breakthrough Pain

A

 In addition to regular pain most patients
experience pain flares: breakthrough pain
 Need prn order in addition to ATC orders
 Usually: 10% of daily dose q1h prn
 May be associated with a particular activity
◦ Incident pain
 Take prn dose before doing that activity
 Or daily variation of the pain
◦ Dose when pain increases

if exceed max, neeed reassessment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

All Aspects of Suffering

Identify & Treat Underlying
Causes

A

 Address the
physical,
psychological,
spiritual and
social problems
the patient may
be experiencing

 If appropriate
◦ Tumors
 Palliative
chemotherapy
 Palliative
radiation
 Palliative surgery
◦Infections
 Antibiotics
◦ Constipation
 Laxatives

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Step 1: Acetaminophen

A

 Used as mild analgesic and adjuvant
 Maximum dose (from all sources)
◦ 4000mg/day
 Should only be short-term in healthy adults
◦ 3000 mg/day
 Long term use in healthy adults (≥ 7 days)
◦ 2000mg /day or avoid
 Heavy alcohol use, malnutrition, low body weight,
advanced age, febrile illness, advanced liver disease,
interacting medications
 Dose restrictions may limit efficacy

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Step 1: NSAIDS

A

 Have traditionally be used for mild cancer pain
 Mild analgesic and adjuvant
 As effective as weak opioids
 Effect in bone pain not as robust as previously
thought: may have benefit in select cases
 Adverse effects limit their use particularly in
elderly/frail population.
◦ GI, kidneys, increased bleed risk
 Ibuprofen, naproxen, diclofenac (honestly rarely used)
◦ Topical diclofenac is used

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Patient Concerns with Opioids

A

 Only used at end of life. With increased survivorship
patients may take these agents for months or years.
Not shown to shorten life when used appropriately.
 Very sedating (can’t drive): patients usually
overcome sedation after a few days.
 Addiction: Majority of patients do not become
addicted. Dose increases over time may be due to
tolerance. Monitor closely.
 If started too early there will be no no options at
the end. Pain does not necessarily increase at the
end of life. Doses can be increased or switch agents

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Start Low & Go Slow

A

 When initiating opioids start at lower doses
 Dose reduce in presence of frailty or organ
dysfunction
 Up-titrate slowly to effect
 Monitor for adverse events
◦ Prescribe laxatives to prevent constipation
 Naloxone kit (call ambulance)
◦ Patient may have pain crisis if used (immediate)
- controversy for palliative pop, have it for ppl in the house who make help take their opioids for them

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Step 2: Codeine

A

 Exhibit a ceiling effect: Maximum effect
 Naturally occurring opioid.
 ~ 1/10 as potent as morphine
 Metabolized to morphine
◦ Via CYP 2D6
 Genetic polymorphism may alter metabolism
 Drug interactions
 Dose
◦ Start 8-15 mg
◦ Maximum: 300 to 400 mg
 Single agent or combination
 Long-acting forms available

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Step 2: Tramadol

A

 Weak opioid & inhibitor of norepinephrine &
serotonin reuptake
 Liver metabolized
 Dose: 50 to 100 mg every 6 hrs
 Maximum dose= 400 to 600mg daily
 Adverse effects ;
◦ Nausea & dizziness are transient
 Care with seizure disorders, raised ICP, hepatic and
renal impairment
 Care TCA’s & SSRI’s (lower seizure threshold)
 Long-acting formulations available
 Not covered by many drug plans

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Strong

A

Opioid Suggested starting dose
Morphine 5 to 10 mg PO q4h atc
Hydromorphone 1 to 2 mg po q4h atc
Oxycodone 2.5 to 5 mg po q4h atc
Fentanyl 25 mcg/h (Do not use 1st –line)
Methadone Dose varies (Do not use 1st line)

Consider dose reductions in the elderly/frail, opioid-naïve patient

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Adverse Effects of Opioid

A

 Early/Acute
◦ Usually resolve
 Nausea
 Sedation
 Respiratory depression
 Pruritus
 Urinary symptoms
◦ Except
 Constipation

 Late/Chronic
◦ Constipation
◦ Hypogonadism
◦ Neurotoxicity
◦ Tolerance
◦ Addiction
◦ Withdrawal

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Fentanyl

A

 Potent (100 x stronger than morphine)
 Not active orally
◦ Transdermal patches
◦ Injectable
 Intermittent: Incident pain
 Rapid onset, short acting
 Use 15 minutes prior to aggravating activity
 Continuous infusion (subcut or IV)
◦ Sublingual - but very expensive
◦ Intranasal (no commercial product available)
 Do not use if opioid-naïve
 Not covered by many drug plans

17
Q

Conversion to Fentanyl Patch

A

Morphine oral dose
mg/24 hrs
TD Fentanyl
mcg/hr q72h
45-134 25
135-224 50
225-314 75
315-404 100
405-494 125
495-584 150
585-674 175
675-764 200\

12 h to stady state, need to bridge so they dont have pain

18
Q

Sublingual Fentanyl

A

 Sublingual tablets
◦ Abstral
 Buccal tablets
◦ Fentora
 Expensive
◦ Not covered by 3rd
parties
◦ Hospital formulary
 Compounding
pharmacies
 Can use the
injectable
sublingually
 50 mcg/mL
 Measure dose in
syringe & hold under
the tongue as long
as possible

dosed q8h for the patient
no adjustment for renal failure

19
Q

methadone as analgesic

A

 Renewed interest
◦ Low cost
◦ Activity against
neuropathic pain
syndromes
◦ ↓ neurotoxicity
 Receptors
◦ μ, k & δ (agonist)
◦ NMDA receptors
(antagonist)
◦ Norepinephrine &
serotonin reuptake
 Metabolism
◦ CYP 3A4
Induced or inhibited
◦ CYP 1A2
 Induced or inhibited
◦ CYP 2D6
 Depends on
polymorphism

20
Q

methadone drug interaction

A


↓ Methadone ◦ Antiretrovirals  Nevirapine  Ritonavir ◦ Phenytoin ◦ Carbamazepine ◦ Dexamethasone ◦ Rifampin ◦ Spironolactone ◦ Alcohol/tobacco

 ↑Methadone ◦ Cimetidine ◦ Omeprazole (not on hospital formulary(◦ Ketoconazole ◦ Fluconazole ◦ SSRI’s ◦ Verapamil ◦ Ciprofloxacin ◦ Macrolides

21
Q

methadone and ATc interval

A

 Prolongs QTc
interval
 Dose related (300-
600mg/day)
 Not usually a concern in
palliative patients
 Cumulative with other
agents: avoid if possible
◦ Levofloxacin
◦ Fluconazole
◦ Arsenic

22
Q

methadoe tx advantages

A

 Advantages
◦ Potent and effective
analgesic
◦ Inexpensive
◦ Fewer neuro-toxicities
◦ Long T1/2 (fewer daily
doses)
 Neuropathic pain
◦ NMDA receptors
◦ NOR & 5HT
 Can be administered to
those highly tolerant to
other agents
 Incomplete crosstolerance helps control
intractable pain
 Tablets and syrup
commercially available

23
Q

Methadone as a Co-analgesic

A

 Using low dose methadone in addition to
regular opioid
 Does not necessitate full methadone rotation
◦ No hospitalization, rapid initiation, less expertise
required.
 Patient does not get the full benefit of
methadone - downside
 Difficult to determine origins of toxicities with
more than opioid on board

Ppl unable to do complete methadone rotation

 North America 3rd
or 4th line
 Europe &
developing
countries often 2nd
line after
morphine

24
Q

methadone disadvantages

A

◦ Kinetics unpredictable
 Courses for prescribers
◦ Rectal & injectable
forms not
commercially available
 Compounding
pharmacies

other receptors involved, not straight conversion

25
Q

Naloxone Kits

A

 Provide if
◦ Non-compliance
expected
◦ May be taken by others
 Explain administration
may precipitate a pain
crisis
Naloxone Kits
* Breathing will change close to death
* Do not mistake for opioid toxicity
* CALL AMBULANCE if administered

if respiratios go down, hold dose and wait as it takes long time towear off

26
Q

adjuvants used in cancer pain

A

 Acetaminophen
 NSAIDS/ASA
 Gabapentin & pregabalin ◦ Neuropathic pain
 Bisphosphonates ◦ Reduces skeletal events (fractures)
 Corticosteroids ◦ Reduce swelling
 Anesthetics ◦ Locally for sores ◦ Intrathecal ◦ Ketamine Bursts - large doses for a few days and stop or continious (quite sedating)

 Chemo & RT  Physiotherapy  Psychotherapy

27
Q

ASA, Acetaminophen, NSAIDs

A

 Used in Step 1
◦ Mild cancer pain
 Used in any step as an
adjuvant
 Value as adjuvant in
Step 3 (strong opioids)
is questionable
 Adverse effects
ASA, Acetaminophen, NSAIDs
* Acetaminophen: Maximum doses. Care in liver mets/failure
* ASA & NSAIDs: Gastric, renal, ↑ bleed risk, corticosteroids

28
Q

Gabapentin & Pregabalin

A

 Used for neuropathic pain
◦ Gabapentin start at 100 to 300 mg hs and increase
to 900-3600mg/day in 2-3 divided doses
◦ Pregabalin start at 25-75 mg po bid and increase
upto 300 mg po bid
 Adverse effects include sedation, cognitive
disturbances, peripheral edema, ataxia &
depression
 Do not discontinue abruptly

29
Q

Antidepressants

A

 Duloxetine start at 30 mg daily and increase
up to 120 mg daily
 Venlafaxine has been used but difficult to
discontinue
 Tricyclic antidepressants can be useful but can
have profound anticholinergic side-effects
 Carbamazepine, valproic acid & phenytoin no
longer recommended as 1st
-line. not used much

30
Q

Corticosteroids

A

 Useful in bone, neuropathic, & visceral pain
 MOA related to their anti-inflammatory
properties
 Useful for short courses of therapy (1 to 3
weeks) to manage pain crises
 Avoid long-term use use: side effects
◦ Hyperglycemia, Cushing’s syndrome, psychiatric,
agitation, delirium, muscle weakness (reversible on
discontinuation
 If long-term use necessary (eg: brain cancer)
use lowest possible dose.

shrink tumours

31
Q

Dexamethasone

A

 Cortico-steroid of choice
 6.7 times more potent than prednisone
 Minimum mineralcorticosteroid effects
◦ Less fluid retention
 Prednisolone causes less proximal myopathy
than dexamethasone.
 8 mg up to qid for severe symptoms
 Taper dose if taking for longer than 2 weeks
 Increase risk of gastric ulceration if take with
NSAIDS

32
Q

Bisphosphonates

A

 Clodronate (po), pamidronate (IV), zoledronic
acid (IV)
◦ Hypercalcemia
 Pamidronate or zoledronic acid if refractory to
pamidronate
◦ Prevention of skeletal events (fractures)
 Reduce risk by up to 30% after 3 months treatment
 Multiple myeloma & breast cancer regular
bisphosphonate if extensive bone involvement
 May have use in other cancers with bone metastases
 Lung, prostate , colon

◦ Bone pain
 Short-term (Zoledronic acid for prostate cancer)
 Use for bone pain is controversial (& expensive)

A lot of pall pt have low albumin
Must correct
Or can OD by giving hem too much calc supplemetnatio
renal fxn adjustmnet

 Use with caution in renal impairment

33
Q

 Clodronante 1600 mg po not well tolerated

A

◦ 4 large capsules on an empty stomach & no food
for 1 hour post treatment
◦ Cannot lie down after taking meds (prevent
esophagitis)
◦ PO use only for prevention of skeletal events
◦ Clodronate injection (subcut) is no longer available
 Other adverse effects include
◦ Flu-like symptoms for a few days post-infusion
◦ Osteonecrosis of mandible reported with
pamidronate and zoledronic acid
used to do it more for multiple myeloma

34
Q

Other Agents

A

 Ketamine may be of use when traditional
agents have failed
 Topical anesthetics (lidocaine) to inflamed
tissue (mouth sores, coccyx ulcers)
 Canabinoids (Sativex®) only cannabinoid
indicated in cancer pain has yielded mixed
results in studies
 Palliative chemo, radiation, or surgery as
indicated

35
Q

Non-Pharmacological

A

 Psychosocial support
◦ Psychologist/counselling
◦ Psychiatrist if needed (previous mental illness)
◦ Meditation
 Spiritual support
◦ Chaplain
 Physiotherapy
 Pet therapy
 Music therapy
 Yoga, Reiki
 Acupuncture